Metraipolis › archive › dc_ee0e4bad05b2

Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy — Europe PMC PMID:41670625

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41670625
DOI
10.1084/jem.20252289
License (as archived)
solo-consultazione
Archived
2026-10-08T14:59:56.793Z
SHA-256 of the archived text
4fda07faa09930f16e34bc55261a4468b1d1e5670f95dd741e203a984de719e2
Stable URL of this page
https://metraipolis.com/documento/dc_ee0e4bad05b2

How to cite

Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy — Europe PMC PMID:41670625 — Europe PMC (en), https://europepmc.org/article/MED/41670625 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee0e4bad05b2 (Metraipolis archive dc_ee0e4bad05b2, sha256 4fda07faa09930f16e34bc55261a4468b1d1e5670f95dd741e203a984de719e2)
BibTeX
@misc{dcee0e4bad05b2,
  title = {Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy — Europe PMC PMID:41670625},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41670625},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee0e4bad05b2; sha256 4fda07faa09930f16e34bc55261a4468b1d1e5670f95dd741e203a984de719e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41670625. Agents can read the archived copy with the MCP tool read_document.